(Q35064978)

6 August 2017

title

The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler (English)

1 reference

6 August 2017

Gaia Colombo

5

0 references

Paul Young

object named as

Paul M Young

6

0 references

Daniela Traini

object named as

Daniela Traini

7

0 references

Mehra Haghi

3

object named as

Mehra Haghi

1 reference

6 August 2017

Alessandro Saadat

1

1 reference

6 August 2017

Bing Zhu

2

1 reference

6 August 2017

Gregory King

4

1 reference

6 August 2017

language of work or name

1 reference

11 December 2013

1 reference

Journal of Pharmacy and Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

66

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

639-645

1 reference

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Diffuse panbronchiolitis in East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Role of macrolide therapy in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Inflammation, chronic obstructive pulmonary disease and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Macrolide effects on the prevention of COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Preventing COPD exacerbations with macrolides: a review and budget impact analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Azithromycin for prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Absolute bioavailability of clarithromycin after oral administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Macrolide antibiotics and cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Advantages of pressurized canister metered dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Propellant-driven metered-dose inhalers for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

A novel apparatus for the determination of solubility in pressurized metered dose inhalers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Measurement and correlation of solute solubility in HFA-134a/ethanol systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

Factors affecting solubility and penetration of clarithromycin through gastric mucus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

The Relative Influence of Atomization and Evaporation on Metered Dose Inhaler Drug Delivery Efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJPHP.12190

21 January 2018

Identifiers

DOI

10.1111/JPHP.12190

1 reference

6 August 2017

1 reference